Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease osteoporosis
Symptom C0599750|hormone deficiency
Sentences 2
PubMedID- 24800251 As the only approved anabolic agent, intermittent pth therapy has been demonstrated to have beneficial effects on increasing bone mass and diminishing bone fragility associated with osteoporosis resulting from aging, sex hormone deficiency, and glucocorticoids use .
PubMedID- 22426695 osteoporosis associated with ovarian hormone deficiency following menopause can be caused by inadequate peak bone mass, excessive bone resorption and inadequate bone formation23, 24. the ovariectomized rat model is a classic model for conducting osteoporosis studies25, 26. in the current study, fdp-sr counteracted the bone loss induced by ovariectomy, preserved bone microarchitecture and maintained bone strength in ovx rats.

Page: 1